Currently, a variety of therapeutic strategies against Nectin-4 are used for cancer treatment, including bioactive/synthetic compounds (e.g., nanoquinacrine) [38], antibody–drug conjugates (ADCs) [39], and oncolytic viruses [40]. The gene discussed is NECTIN4; the disease is cancer.